We are live on ! Find out more
CGON icon

CG Oncology
CGON

176 hedge funds and large institutions have $3.13B invested in CG Oncology in 2025 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 54 increasing their positions, 57 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

562% more call options, than puts

Call options by funds: $7.79M | Put options by funds: $1.18M

79% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 19

58% more capital invested

Capital invested by funds: $1.97B → $3.13B (+$1.15B)

33% more funds holding in top 10

Funds holding in top 10: 9 → 12 (+3)

9% more funds holding

Funds holding: 162 → 176 (+14)

2.25% more ownership

Funds ownership: 99.59% → 101.84% (+2.2%)

5% less repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 57

Holders
176
Holders Change
+14
Holders Change %
+8.64%
% of All Funds
2.31%
Holding in Top 10
12
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+33.33%
% of All Funds
0.16%
New
34
Increased
54
Reduced
57
Closed
19
Calls
$7.79M
Puts
$1.18M
Net Calls
+$6.61M
Net Calls Change
-$7.2M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$105M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$19.5M
3
ClearBridge Investments
ClearBridge Investments
New York
+$17.8M
4
CS
Candriam SCA
Luxembourg
+$7.97M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$5.62M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$35.6M
2
Bank of America
Bank of America
North Carolina
-$28.7M
3
Millennium Management
Millennium Management
New York
-$20.5M
4
FLSM
Frazier Life Sciences Management
California
-$20M
5
KCM
Kynam Capital Management
New Jersey
-$13.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$265M +$19.5M +670,770 +11%
DC
2
Decheng Capital
California
$257M – – –
Wellington Management Group
3
Wellington Management Group
Massachusetts
$222M +$105M +3,613,885 +190%
BlackRock
4
BlackRock
New York
$185M +$3.78M +130,091 +3%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$156M +$277K +9,541 +0.2%
TCM
6
TCG Crossover Management
California
$148M – – –
B
7
Braidwell
Connecticut
$132M – – –
FCMV
8
Foresite Capital Management VI
California
$89.5M – – –
AllianceBernstein
9
AllianceBernstein
Tennessee
$86.1M -$759K -26,095 -1%
UBS Group
10
UBS Group
Switzerland
$85.6M -$2.99M -102,975 -5%
State Street
11
State Street
Massachusetts
$82.4M -$3.46M -119,086 -5%
KCM
12
Kynam Capital Management
New Jersey
$80.8M -$13.2M -452,462 -18%
O
13
OrbiMed
New York
$69.6M -$4.39M -151,000 -8%
RI
14
RTW Investments
New York
$68.5M – – –
APM
15
Avidity Partners Management
Texas
$64.5M +$2.94M +100,957 +7%
T. Rowe Price Associates
16
T. Rowe Price Associates
Maryland
$64M -$12.4M -424,932 -21%
Point72 Asset Management
17
Point72 Asset Management
Connecticut
$61.4M +$1.4M +48,116 +3%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$59.4M +$4M +137,736 +10%
Franklin Resources
19
Franklin Resources
California
$59.2M -$510K -17,536 -1%
Goldman Sachs
20
Goldman Sachs
New York
$55.1M +$5.23M +179,770 +15%
Pictet Asset Management
21
Pictet Asset Management
Switzerland
$53.1M -$1.04M -35,816 -3%
ACA
22
Acorn Capital Advisors
New York
$45.6M – – –
PCH
23
Polar Capital Holdings
United Kingdom
$44.3M – – –
CS
24
Candriam SCA
Luxembourg
$41.8M +$7.97M +274,312 +36%
FCMV
25
Foresite Capital Management V
California
$40.4M – – –
1
2 3 4 5

CGON Hedge Fund Activity: Q3 2025 in Review

176 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in CG Oncology (CGON) for Q3 2025, worth a combined $3.13B — up 58% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new CGON positions and 19 closed out — a net gain of 15 holders — while 54 added to existing stakes and 57 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $105M. The largest seller was Morgan Stanley, cutting an estimated $35.6M.

  • 176 institutional investors held CG Oncology (CGON) as of Q3 2025, up from 162 in Q2 2025.
  • Funds reported $3.13B of CG Oncology stock for Q3 2025, up 58% quarter-over-quarter.
  • 34 funds opened new CG Oncology positions in Q3 2025 and 19 closed out, a net change of +15 holders.
  • The largest CG Oncology buyer in Q3 2025 was Wellington Management Group, an estimated $105M added.
  • The largest CG Oncology seller in Q3 2025 was Morgan Stanley, an estimated $35.6M sold.

Based on aggregated 13F filings for Q3 2025.